Response to "Does amantadine have a protective effect against COVID-19?"

被引：2
作者：
Tipton, Philip W. [1 ]
Wszolek, Zbigniew K. [1 ]
机构：
[1] Mayo Clin, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
来源：
NEUROLOGIA I NEUROCHIRURGIA POLSKA | 2020年 / 54卷 / 03期
关键词：
D O I：
10.5603/PJNNS.a2020.0048
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：286 / 287
页数：2
相关论文
共 9 条
[1]   Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility [J].
Arons, M. M. ;
Hatfield, K. M. ;
Reddy, S. C. ;
Kimball, A. ;
James, A. ;
Jacobs, J. R. ;
Taylor, J. ;
Spicer, K. ;
Bardossy, A. C. ;
Oakley, L. P. ;
Tanwar, S. ;
Dyal, J. W. ;
Harney, J. ;
Chisty, Z. ;
Bell, J. M. ;
Methner, M. ;
Paul, P. ;
Carlson, C. M. ;
McLaughlin, H. P. ;
Thornburg, N. ;
Tong, S. ;
Tamin, A. ;
Tao, Y. ;
Uehara, A. ;
Harcourt, J. ;
Clark, S. ;
Brostrom-Smith, C. ;
Page, L. C. ;
Kay, M. ;
Lewis, J. ;
Montgomery, P. ;
Stone, N. D. ;
Clark, T. A. ;
Honein, M. A. ;
Duchin, J. S. ;
Jernigan, J. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) :2081-2090
[2]   Novel Treatment with Neuroprotective and Antiviral Properties against a Neuroinvasive Human Respiratory Virus [J].
Brison, Elodie ;
Jacomy, Helene ;
Desforges, Marc ;
Talbot, Pierre J. .
JOURNAL OF VIROLOGY, 2014, 88 (03) :1548-1563
[3]   Does amantadine have a protective effect against COVID-19? [J].
Cortes Borra, Albert .
NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (03) :284-285
[4]   COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy [J].
Fasano, Alfonso ;
Cereda, Emanuele ;
Barichella, Michela ;
Cassani, Erica ;
Ferri, Valentina ;
Zecchinelli, Anna Lena ;
Pezzoli, Gianni .
MOVEMENT DISORDERS, 2020, 35 (07) :1089-1093
[5]   SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration [J].
Lippi, Alice ;
Domingues, Renato ;
Setz, Cristian ;
Outeiro, Tiago F. ;
Krisko, Anita .
MOVEMENT DISORDERS, 2020, 35 (05) :716-720
[6]   Ageing and Parkinson's disease: Why is advancing age the biggest risk factor? [J].
Reeve, Amy ;
Simcox, Eve ;
Turnbull, Doug .
AGEING RESEARCH REVIEWS, 2014, 14 :19-30
[7]   Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment [J].
Rejdak, Konrad ;
Grieb, Pawel .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
[8]   Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [J].
Richardson, Safiya ;
Hirsch, Jamie S. ;
Narasimhan, Mangala ;
Crawford, James M. ;
McGinn, Thomas ;
Davidson, Karina W. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20) :2052-2059
[9]   What can Parkinson's disease teach us about COVID-19? [J].
Tipton, Philip W. ;
Wszolek, Zbigniew K. .
NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (02) :204-206
1